Price T Rowe Associates Inc Natera, Inc. Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Natera, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 12,187,816 shares of NTRA stock, worth $1.95 Billion. This represents 0.23% of its overall portfolio holdings.

Number of Shares
12,187,816
Previous 10,537,743 15.66%
Holding current value
$1.95 Billion
Previous $1.49 Billion 38.18%
% of portfolio
0.23%
Previous 0.18%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$132.23 - $171.87 $218 Million - $284 Million
1,650,073 Added 15.66%
12,187,816 $2.06 Billion
Q1 2025

May 14, 2025
BUY
$132.63 - $177.0 $503 Million - $672 Million
3,795,315 Added 56.29%
10,537,743 $1.49 Billion
Q4 2024

Feb 14, 2025
BUY
$117.67 - $174.0 $456 Million - $674 Million
3,871,862 Added 134.88%
6,742,428 $1.07 Billion
Q3 2024

Nov 14, 2024
BUY
$97.75 - $129.67 $229 Million - $304 Million
2,341,756 Added 442.84%
2,870,566 $364 Million
Q2 2024

Aug 14, 2024
SELL
$85.28 - $112.6 $12 Million - $15.9 Million
-141,151 Reduced 21.07%
528,810 $57.3 Million
Q1 2024

May 15, 2024
BUY
$59.21 - $92.9 $7.21 Million - $11.3 Million
121,809 Added 22.22%
669,961 $61.3 Million
Q4 2023

Feb 14, 2024
SELL
$37.55 - $62.64 $3.09 Million - $5.15 Million
-82,261 Reduced 13.05%
548,152 $34.3 Million
Q3 2023

Nov 14, 2023
SELL
$43.4 - $62.52 $4.14 Million - $5.97 Million
-95,466 Reduced 13.15%
630,413 $27.9 Million
Q2 2023

Aug 14, 2023
BUY
$47.08 - $55.16 $2.63 Million - $3.08 Million
55,795 Added 8.33%
725,879 $35.3 Million
Q1 2023

May 15, 2023
BUY
$36.57 - $58.29 $4.98 Million - $7.93 Million
136,072 Added 25.48%
670,084 $37.2 Million
Q4 2022

Feb 14, 2023
BUY
$34.17 - $47.91 $2.62 Million - $3.67 Million
76,610 Added 16.75%
534,012 $21.5 Million
Q3 2022

Nov 14, 2022
BUY
$36.93 - $56.68 $15 Million - $23 Million
406,276 Added 794.66%
457,402 $20 Million
Q2 2022

Aug 15, 2022
BUY
$28.13 - $44.54 $254,435 - $402,864
9,045 Added 21.49%
51,126 $1.81 Million
Q1 2022

May 16, 2022
SELL
$30.32 - $91.33 $3.06 Million - $9.22 Million
-100,940 Reduced 70.58%
42,081 $1.71 Million
Q4 2021

Feb 14, 2022
SELL
$86.26 - $119.0 $331,410 - $457,198
-3,842 Reduced 2.62%
143,021 $13.4 Million
Q3 2021

Nov 15, 2021
BUY
$100.17 - $126.36 $822,996 - $1.04 Million
8,216 Added 5.93%
146,863 $16.4 Million
Q2 2021

Aug 16, 2021
BUY
$86.05 - $119.72 $8.81 Million - $12.3 Million
102,345 Added 281.93%
138,647 $15.7 Million
Q1 2021

May 17, 2021
SELL
$91.47 - $124.36 $119,093 - $161,916
-1,302 Reduced 3.46%
36,302 $3.69 Million
Q4 2020

Feb 16, 2021
BUY
$66.66 - $111.74 $2.51 Million - $4.2 Million
37,604 New
37,604 $3.74 Million

Others Institutions Holding NTRA

# of Institutions
703
Shares Held
125M
Call Options Held
552K
Put Options Held
271K
View Full List

About Natera, Inc.

NTRA Quotes by TradingView
  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.5B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email